These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28985732)

  • 1. Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa.
    Choi SE; Brandeau ML; Bendavid E
    Malar J; 2017 Oct; 16(1):403. PubMed ID: 28985732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.
    Fernandes S; Sicuri E; Kayentao K; van Eijk AM; Hill J; Webster J; Were V; Akazili J; Madanitsa M; ter Kuile FO; Hanson K
    Lancet Glob Health; 2015 Mar; 3(3):e143-53. PubMed ID: 25701992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi.
    Kapito-Tembo A; Meshnick SR; van Hensbroek MB; Phiri K; Fitzgerald M; Mwapasa V
    J Infect Dis; 2011 Feb; 203(4):464-72. PubMed ID: 21216867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.
    Walker PG; Floyd J; Ter Kuile F; Cairns M
    PLoS Med; 2017 Feb; 14(2):e1002243. PubMed ID: 28245259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
    Sicuri E; Fernandes S; Macete E; González R; Mombo-Ngoma G; Massougbodgi A; Abdulla S; Kuwawenaruwa A; Katana A; Desai M; Cot M; Ramharter M; Kremsner P; Slustker L; Aponte J; Hanson K; Menéndez C
    PLoS One; 2015; 10(4):e0125072. PubMed ID: 25915616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-based strategies to increase coverage of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine in sub-Saharan Africa: a systematic review, meta-analysis, meta-ethnography, and economic assessment.
    Koita K; Kayentao K; Worrall E; Van Eijk AM; Hill J
    Lancet Glob Health; 2024 Sep; 12(9):e1456-e1469. PubMed ID: 39151981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of intermittent preventive treatment with dihydroartemisinin-piperaquine for malaria during pregnancy: an analysis using efficacy results from Uganda and Kenya, and pooled data.
    Fernandes S; Were V; Gutman J; Dorsey G; Kakuru A; Desai M; Kariuki S; Kamya MR; Ter Kuile FO; Hanson K
    Lancet Glob Health; 2020 Dec; 8(12):e1512-e1523. PubMed ID: 33137287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
    Klement E; Pitché P; Kendjo E; Singo A; D'Almeida S; Akouete F; Akpaloo Y; Tossa K; Prince-Agbodjan S; Patassi A; Caumes E
    Clin Infect Dis; 2014 Mar; 58(5):651-9. PubMed ID: 24336820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of intermittent preventive treatment of malaria in pregnancy and risk factors for maternal anaemia and low birthweight among HIV-negative mothers in Dschang, West region of Cameroon: a cross sectional study.
    Kamga SLS; Ali IM; Ngangnang GR; Ulucesme MC; Keptcheu LTD; Keming EM; Tchuenkam VK; Foyet JV; Aktas M; Noubom M; Payne VK
    Malar J; 2024 Jan; 23(1):6. PubMed ID: 38178125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The readiness of malaria services and uptake of intermittent preventive treatment in pregnancy in six sub-Saharan countries.
    Xu X; Liang D; Zhao J; Mpembeni R; Olenja J; Yam EL; Huang J
    J Glob Health; 2024 Jun; 14():04112. PubMed ID: 38939971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sulfadoxine-pyrimethamine for the prevention of malaria-associated low birth weight.
    Wolfe EB; Parise ME; Haddix AC; Nahlen BL; Ayisi JG; Misore A; Steketee RW
    Am J Trop Med Hyg; 2001; 64(3-4):178-86. PubMed ID: 11442215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.
    Conteh L; Sicuri E; Manzi F; Hutton G; Obonyo B; Tediosi F; Biao P; Masika P; Matovu F; Otieno P; Gosling RD; Hamel M; Odhiambo FO; Grobusch MP; Kremsner PG; Chandramohan D; Aponte JJ; Egan A; Schellenberg D; Macete E; Slutsker L; Newman RD; Alonso P; Menéndez C; Tanner M
    PLoS One; 2010 Jun; 5(6):e10313. PubMed ID: 20559558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
    Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
    Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight.
    Desai M; Gutman J; Taylor SM; Wiegand RE; Khairallah C; Kayentao K; Ouma P; Coulibaly SO; Kalilani L; Mace KE; Arinaitwe E; Mathanga DP; Doumbo O; Otieno K; Edgar D; Chaluluka E; Kamuliwo M; Ades V; Skarbinski J; Shi YP; Magnussen P; Meshnick S; Ter Kuile FO
    Clin Infect Dis; 2016 Feb; 62(3):323-333. PubMed ID: 26486699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaling-up the use of sulfadoxine-pyrimethamine for the preventive treatment of malaria in pregnancy: results and lessons on scalability, costs and programme impact from three local government areas in Sokoto State, Nigeria.
    Orobaton N; Austin AM; Abegunde D; Ibrahim M; Mohammed Z; Abdul-Azeez J; Ganiyu H; Nanbol Z; Fapohunda B; Beal K
    Malar J; 2016 Nov; 15(1):533. PubMed ID: 27814763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.